drugset / Trial / NCT03664011
A Study in Healthy Men to Test How BI 730357 is Processed by the Body
NaSingle-groupOpen-labelTreatment
Summary
The main objectives of the study are as follows: * To assess the mass balance recovery of (C-14) BI 730357-radioactivity (also expressed as 14C-BI 730357-EQ) in urine and faeces after a single oral dose of 50 mg BI 730357 base (BS) (C-14) in healthy male subjects * To provide plasma, urine, and faecal samples for metabolite profiling and structural identification
Timeline
- Start
- 2018-09-10
- Primary completion
- 2018-11-13
- Completion
- 2018-11-13
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | BI 730357 | Unknown | 50 mg | Oral |
Indications
No indication recorded.